Brad Langhorst
Product Development Group Leader - New England Biolabs
Sequencing Finishing and the Future 2020-12-03
Brad Langhorst - New England Biolabs
UMI added here
= technical factors contributing to observed abundance
UMIs duplicated here
BRCA1
p53
Original
Library
+ UMI
Fragments
2
1
3
4
5
6
7
9
1
2
3
4
5
PCR
1
1
1
2
2
3
4
4
4
4
4
4
5
6
7
8
9
5
6
7
8
9
1
2
3
4
5
1
2
3
4
5
2
3
4
5
4
4
4
5
9
9
8
8
25/18 = 1.8
9/5 = 1.4
BRCA1/p53 ratio
4/3 = 1.3
Dedup
1
1
1
2
2
8
9
8
9
9
9
8
Using UMI
No UMI
BRCA1
Alignment
1
2
9
= 12
= 3
1
1
1
2
2
8
9
8
9
9
9
8
1
2
8
9
= 4
= 12
BRCA1
BRCA1
BRCA1
C. Devoe, D. Posfai, K. Krishnan, D. Rodriguez
Goal: Compare counts of transcripts with and without UMI
Hard to Amplify
Easy to Amplify
G. Naishadham
Goal: Compare counts of transcripts to expectation
G. Naishadham
G. Naishadham
G. Naishadham
Increasing Duplication
transcripts with > 100 reads
Increasing Duplication
G. Naishadham
transcripts with > 100 reads
Increasing Duplication
Increasing Predicted Stability
transcripts with > 100 reads
G. Naishadham
PS: I'm hiring soon - see the job board!
By Brad Langhorst
Product Development Group Leader - New England Biolabs